James G Martin Selected Research

Chlorine

1/2021	Differential Regulation of the Asthmatic Phenotype by the Aryl Hydrocarbon Receptor.
11/2020	Cellular Source of Cysteinyl Leukotrienes Following Chlorine Exposure.
10/2019	Tolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury.
10/2017	Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.
1/2017	Inflammation and airway hyperresponsiveness after chlorine exposure are prolonged by Nrf2 deficiency in mice.
4/2015	Neutrophils mediate airway hyperresponsiveness after chlorine-induced airway injury in the mouse.
10/2010	Dimethylthiourea protects against chlorine induced changes in airway function in a murine model of irritant induced asthma.
7/2010	Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models.
8/2008	Time course of airway remodelling after an acute chlorine gas exposure in mice.
9/2003	Chlorine-induced injury to the airways in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James G Martin Research Topics

Disease

59	Asthma (Bronchial Asthma) 10/2022 - 05/2002
44	Inflammation (Inflammations) 10/2022 - 05/2002
28	Respiratory Hypersensitivity 11/2020 - 01/2003
20	Airway Remodeling 01/2017 - 12/2002
14	Eosinophilia 01/2019 - 05/2002
8	Pneumonia (Pneumonitis) 01/2019 - 08/2010
7	Hyperplasia 07/2012 - 09/2003
5	Fibrosis (Cirrhosis) 11/2023 - 08/2008
5	Infections 01/2022 - 01/2012
4	Virus Diseases (Viral Diseases) 01/2019 - 01/2006
4	Hypersensitivity (Allergy) 01/2018 - 06/2007
4	Cystic Fibrosis (Mucoviscidosis) 04/2013 - 11/2005
3	Lung Injury 10/2019 - 03/2011
2	Acute Lung Injury 01/2023 - 07/2013
2	Emphysema 01/2021 - 01/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019 - 06/2015
2	Airway Obstruction (Choking) 11/2018 - 02/2014
2	Occupational Asthma 05/2017 - 09/2003
2	Respiratory Sounds (Crackle) 04/2013 - 07/2010
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2023
1	Disease Progression 10/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Human Influenza (Influenza) 01/2022
1	COVID-19 11/2021
1	Hyperoxia 01/2021

Drug/Important Bio-Agent (IBA)

26	AllergensIBA 01/2022 - 05/2002
21	CytokinesIBA 01/2019 - 01/2007
11	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2003
11	OvalbuminIBA 01/2021 - 01/2003
10	ChlorineIBA 01/2021 - 09/2003
9	Methacholine Chloride (Methacholine)FDA Link 10/2017 - 08/2008
8	Interleukin-5 (Interleukin 5)IBA 01/2019 - 10/2002
7	Irritants (Vesicants)IBA 01/2021 - 07/2010
7	Interleukin-13IBA 01/2018 - 05/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 04/2007
6	Interleukin-4 (Interleukin 4)IBA 01/2018 - 10/2002
6	AntigensIBA 11/2013 - 03/2005
5	AntioxidantsIBA 11/2023 - 10/2010
5	Interleukin-8 (Interleukin 8)IBA 04/2013 - 09/2005
5	Messenger RNA (mRNA)IBA 08/2012 - 10/2002
4	Biomarkers (Surrogate Marker)IBA 05/2017 - 11/2006
4	ChemokinesIBA 09/2015 - 01/2007
4	Interleukin-17 (Interleukin 17)IBA 09/2015 - 04/2010
3	Fluticasone (Cutivate)FDA LinkGeneric 10/2022 - 11/2012
3	SteroidsIBA 10/2022 - 08/2010
3	AntibodiesIBA 01/2022 - 05/2003
3	InterleukinsIBA 10/2020 - 01/2003
3	LeukotrienesIBA 10/2017 - 01/2003
3	1,3-dimethylthioureaIBA 01/2016 - 10/2010
3	LigandsIBA 04/2012 - 06/2007
2	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023 - 01/2021
2	Pancreatic Elastase (Elastase)IBA 01/2021 - 01/2006
2	Prednisone (Sone)FDA LinkGeneric 10/2020 - 01/2018
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2019 - 04/2012
2	montelukast (Singulair)FDA Link 10/2017 - 01/2003
2	LipidsIBA 10/2017 - 01/2004
2	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 10/2017 - 01/2016
2	Bronchodilator Agents (Bronchodilators)IBA 05/2017 - 08/2010
2	EnzymesIBA 01/2017 - 01/2012
2	Oxidants (Oxidizing Agents)IBA 01/2017 - 10/2011
2	ProtollinIBA 01/2017 - 09/2012
2	Chemotactic FactorsIBA 01/2016 - 01/2004
2	Antiviral Agents (Antivirals)IBA 05/2014 - 08/2010
2	Interleukin-22 (IL-22)IBA 11/2013 - 12/2012
2	Oxidoreductases (Dehydrogenase)IBA 07/2013 - 08/2010
2	Histamine (Histamine Dihydrochloride)FDA Link 04/2013 - 04/2012
2	Immunoglobulin E (IgE)IBA 08/2012 - 01/2004
2	ErbB Receptors (EGF Receptor)IBA 04/2012 - 06/2010
2	Proteoglycans (Proteoglycan)IBA 01/2012 - 06/2006
2	p38 Mitogen-Activated Protein KinasesIBA 11/2011 - 04/2010
2	GlucocorticoidsIBA 11/2011 - 05/2003
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2010 - 05/2010
2	Interleukin-33IBA 03/2010 - 10/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2008 - 11/2006
2	InterferonsIBA 02/2008 - 01/2006
2	OligodeoxyribonucleotidesIBA 10/2007 - 05/2002
2	Metalloproteases (Metalloproteinases)IBA 04/2007 - 01/2007
2	DisintegrinsIBA 04/2007 - 01/2007
2	Adenosine Triphosphate (ATP)IBA 11/2005 - 12/2002
2	Uridine Triphosphate (UTP)IBA 11/2005 - 12/2002
1	LipopolysaccharidesIBA 01/2023
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	ciclesonide FDA Link 11/2021
1	Leukotriene C4IBA 01/2021
1	Monoclonal AntibodiesIBA 10/2020
1	mepolizumabIBA 10/2020
1	reslizumabIBA 10/2020
1	Dinoprostone (PGE2)FDA Link 10/2019
1	Nucleic AcidsIBA 01/2019
1	sulforaphaneIBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019
1	Hydroxyl RadicalIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	benralizumabIBA 01/2018

Therapy/Procedure

8	Therapeutics 11/2018 - 06/2010
1	Bronchial Thermoplasty 01/2019